| __timestamp | Amphastar Pharmaceuticals, Inc. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 7459000 |
| Thursday, January 1, 2015 | 37065000 | 11831000 |
| Friday, January 1, 2016 | 41199000 | 25705000 |
| Sunday, January 1, 2017 | 43415000 | 46181000 |
| Monday, January 1, 2018 | 57564000 | 59497000 |
| Tuesday, January 1, 2019 | 68853000 | 65003000 |
| Wednesday, January 1, 2020 | 67229000 | 74506000 |
| Friday, January 1, 2021 | 60932000 | 126006000 |
| Saturday, January 1, 2022 | 74771000 | 126215000 |
| Sunday, January 1, 2023 | 73741000 | 120161000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, investment in research and development (R&D) is crucial for staying ahead. Over the past decade, Protagonist Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc. have shown distinct strategies in their R&D spending. From 2014 to 2023, Protagonist Therapeutics has consistently increased its R&D expenses, peaking in 2022 with a 1,590% increase from 2014. This aggressive investment underscores their commitment to innovation and development of new therapies. In contrast, Amphastar Pharmaceuticals has maintained a steady growth in R&D spending, with a 163% increase over the same period. While both companies are committed to innovation, Protagonist Therapeutics' strategy reflects a more aggressive approach, potentially positioning them as a leader in breakthrough therapies. This comparison highlights the diverse strategies within the biotech industry and the importance of R&D in driving future growth and success.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc. Allocate Funds
Exelixis, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Pharming Group N.V. vs Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: CRISPR Therapeutics AG and Protagonist Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for CRISPR Therapeutics AG and Amphastar Pharmaceuticals, Inc.
Research and Development Investment: Protagonist Therapeutics, Inc. vs Evotec SE
R&D Spending Showdown: Soleno Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Iovance Biotherapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?